HEART FAILURE, DIASTOLIC
Clinical trials for HEART FAILURE, DIASTOLIC explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE, DIASTOLIC trials appear
Sign up with your email to follow new studies for HEART FAILURE, DIASTOLIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart failure drug enters first human safety trial
Disease control Not yet recruitingThis early-stage trial will test a single dose of a new drug called LY3971297 in 90 people with two types of heart failure: preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF). The main goal is to see if the drug is safe and what side effects occur. Particip…
Matched conditions: HEART FAILURE, DIASTOLIC
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could mounjaro ease heart failure in obesity? new trial investigates
Disease control Not yet recruitingThis study will test whether tirzepatide (Mounjaro), a drug used for diabetes and weight loss, can help people with obesity-related heart failure with preserved ejection fraction (HFpEF). Researchers will measure changes in blood volume and body fat in 50 participants over 15 mon…
Matched conditions: HEART FAILURE, DIASTOLIC
Phase: PHASE4 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Heart failure patients grouped by data, not drugs
Knowledge-focused Not yet recruitingThis study looks at 200 adults with a type of heart failure called HFpEF. Researchers will use medical records and exercise tests to find different patient groups, or phenotypes. The goal is to better understand these groups, not to test any new treatment. Participants will have …
Matched conditions: HEART FAILURE, DIASTOLIC
Sponsor: Instituto Politécnico de Leiria • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC